3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
35
Myelodysplastic Syndromes
28
Precursor Cell Lymphoblastic Leukemia-Lymphoma
26
Hematologic Neoplasms
14
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
13
Lymphoma, Non-Hodgkin
12
Myeloproliferative Disorders
11
Lymphoma
11
Leukemia, Myelomonocytic, Chronic
11
Graft vs Host Disease
10
Primary Myelofibrosis
9
Leukemia
9
Hodgkin Disease
9
Leukemia, Lymphocytic, Chronic, B-Cell
7
Anemia, Refractory, with Excess of Blasts
7
Multiple Myeloma
6
Leukemia, Biphenotypic, Acute
6
Burkitt Lymphoma
5
Polycythemia Vera
4
Lymphoma, Follicular
4
Leukemia, Myeloid
4
Leukemia, Lymphoid
4
Anemia, Aplastic
4
Thrombocythemia, Essential
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precancerous Conditions
3
Neoplasms, Plasma Cell
3
Neoplasms
3
Myelodysplastic-Myeloproliferative Diseases
3
Lymphoproliferative Disorders
3
Interventions
pembrolizumab
69
Nivolumab
69
cabozantinib
45
Ipilimumab
38
Specimen Handling
33
Magnetic Resonance Spectroscopy
33
lenvatinib
26
Axitinib
25
belzutifan
21
Sunitinib
18
Biopsy
15
Radiosurgery
14
CTLA-4 Antigen
13
atezolizumab
12
Everolimus
10
pazopanib
8
fludarabine
8
avelumab
8
Bevacizumab
8
toripalimab
7
cemiplimab
7
Nephrectomy
7
Immunoglobulin G
7
Cyclophosphamide
7
aldesleukin
6
Standard of Care
6
Radiotherapy
6
Blood Specimen Collection
6
spartalizumab
5
palbociclib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Tacrolimus
×
1 year
×
Clear all
No trials found.